These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18656556)

  • 1. Tyrphostin AG-490 inhibited the acute phase of zymosan-induced inflammation.
    Dimitrova P; Ivanovska N
    Int Immunopharmacol; 2008 Nov; 8(11):1567-77. PubMed ID: 18656556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.
    Dugo L; Chatterjee PK; Mazzon E; McDonald MC; Paola RD; Fulia F; Caputi AP; Thiemermann C; Cuzzocrea S
    Intensive Care Med; 2002 Jun; 28(6):775-88. PubMed ID: 12107686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
    Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Caminiti R; Esposito E; Di Bella P; Cuzzocrea S
    Shock; 2008 May; 29(5):560-71. PubMed ID: 17724436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice.
    Mondello S; Galuppo M; Mazzon E; Italiano D; Mondello P; Aloisi C; Cuzzocrea S
    Eur J Pharmacol; 2011 May; 658(1):28-40. PubMed ID: 21349270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
    Di Paola R; Esposito E; Mazzon E; Genovese T; Muià C; Crisafulli C; Malleo G; Sessa E; Meli R; Cuzzocrea S
    Shock; 2006 Nov; 26(5):477-84. PubMed ID: 17047518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvastatin ameliorates endotoxin induced multiple organ failure in conscious rats.
    Chen CH; Lee RP; Wu WT; Liao KW; Hsu N; Hsu BG
    Resuscitation; 2007 Jul; 74(1):166-74. PubMed ID: 17353078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of selective nitric oxide synthase blocker on survival, mesenteric blood flow and multiple organ failure induced by zymosan.
    Tanriverdi P; Yuksel BC; Rasa K; Guler G; Iskit AB; Guc MO; Korkmaz A
    J Surg Res; 2005 Mar; 124(1):67-73. PubMed ID: 15734481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 10 mitigates the development of the zymosan-induced multiple organ dysfunction syndrome in mice.
    Jansen MJ; Hendriks T; de Man BM; van der Meer JW; Goris RJ
    Cytokine; 1999 Sep; 11(9):713-21. PubMed ID: 10479408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody against tumour necrosis factor-alpha improves survival in experimental multiple organ dysfunction syndrome.
    Jansen MJ; Hendriks T; Hermsen R; Van der Meer JW; Goris RJ
    Cytokine; 1998 Nov; 10(11):904-10. PubMed ID: 9878128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice.
    Mazzon E; Esposito E; Di Paola R; Impellizzeri D; Bramanti P; Cuzzocrea S
    Pharmacol Res; 2011 Jul; 64(1):68-79. PubMed ID: 21193041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase.
    Ruetten H; Thiemermann C
    Br J Pharmacol; 1997 Sep; 122(1):59-70. PubMed ID: 9298529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
    Malleo G; Mazzon E; Genovese T; Di Paola R; Caminiti R; Esposito E; Bramanti P; Cuzzocrea S
    Cytokine; 2008 Feb; 41(2):136-43. PubMed ID: 18160304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages.
    Kim BH; Hong SS; Kwon SW; Lee HY; Sung H; Lee IJ; Hwang BY; Song S; Lee CK; Chung D; Ahn B; Nam SY; Han SB; Kim Y
    J Pharmacol Exp Ther; 2008 Nov; 327(2):393-401. PubMed ID: 18694995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model.
    Xie K; Yu Y; Zhang Z; Liu W; Pei Y; Xiong L; Hou L; Wang G
    Shock; 2010 Nov; 34(5):495-501. PubMed ID: 20351628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS).
    Ferrer TJ; Webb JW; Wallace BH; Bridges CD; Palmer HE; Robertson RD; Cone JB
    J Surg Res; 1998 Jul; 77(2):157-64. PubMed ID: 9733603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple organ dysfunction syndrome: end organ and systemic inflammatory response in a mouse model of nonseptic origin.
    Shayevitz JR; Miller C; Johnson KJ; Rodriguez JL
    Shock; 1995 Dec; 4(6):389-96. PubMed ID: 8608394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice.
    Di Paola R; Mazzon E; Genovese T; Crisafulli C; Bramanti P; Caminiti R; Esposito E; Fink MP; Cuzzocrea S
    Crit Care Med; 2009 Jan; 37(1):270-82. PubMed ID: 19050619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of L-NG-nitroarginine in a zymosan-induced multiple organ dysfunction syndrome model.
    Ozel H; Yuksel BC; Berkem H; Avsar FM; Guler G; Iskit AB; Guc MO; Hengirmen S
    Eur Surg Res; 2009; 43(2):211-8. PubMed ID: 19556797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway.
    Ding Y; Zhao L; Mei H; Zhang SL; Huang ZH; Duan YY; Ye P
    Eur J Pharmacol; 2008 Aug; 590(1-3):377-86. PubMed ID: 18590720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.
    Sevransky JE; Shaked G; Novogrodsky A; Levitzki A; Gazit A; Hoffman A; Elin RJ; Quezado ZM; Freeman BD; Eichacker PQ; Danner RL; Banks SM; Bacher J; Thomas ML; Natanson C
    J Clin Invest; 1997 Apr; 99(8):1966-73. PubMed ID: 9109441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.